leflunomide has been researched along with Viral Diseases in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raghuvanshi, R | 1 |
| Bharate, SB | 1 |
| Sanders, JS | 1 |
| Riezebos-Brilman, A | 1 |
| Homan van der Heide, JJ | 1 |
2 other studies available for leflunomide and Viral Diseases
| Article | Year |
|---|---|
Recent Developments in the Use of Kinase Inhibitors for Management of Viral Infections.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Approval; Drug Repositioning; High-Through | 2022 |
Progressive multifocal leuko-encephalopathy after ABO-incompatible kidney transplantation.
Topics: ABO Blood-Group System; Blood Group Incompatibility; Glomerulonephritis, IGA; Humans; Immunosuppress | 2012 |